DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice

  • Post author:
  • Post category:Sales & Growth

DENVER, Oct. 20, 2026 /PRNewswire/ -- DaVita today issued the following statement in response to the U.S. Department of Health and Human Services' Kidney Care National Plan and related remarks regarding the future of kidney care: DaVita shares the…

Continue ReadingDaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice

Tigerlily Foundation Brings Patients, Advocates and Healthcare Leaders to Washington, DC for 20th Anniversary Events Advancing Health

  • Post author:
  • Post category:Sales & Growth

WASHINGTON, Oct. 19, 2026 /PRNewswire/ -- Tigerlily Foundation will mark a milestone 20 years of impact on Saturday, October 24, 2026, with two signature events at the Grand Hyatt Washington: the 4th Annual BEACON Symposium and the 20th Anniversary…

Continue ReadingTigerlily Foundation Brings Patients, Advocates and Healthcare Leaders to Washington, DC for 20th Anniversary Events Advancing Health

New Progress — XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson’s Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment

  • Post author:
  • Post category:Sales & Growth

SEOUL, South Korea and SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- New clinical data for XellSmart's off-the-shelf cell therapy for Parkinson's Disease was presented at the International Congress of Parkinson's Disease and Movement Disorders (MDS), one of the world's…

Continue ReadingNew Progress — XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson’s Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment

Masimo’s smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

  • Post author:
  • Post category:Sales & Growth

Industry-Leading Pulse Oximetry Platform Now Features First-of-Its-Kind Atrial Fibrillation (AFib) Detection with Previously Cleared AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection Designed Together to Deliver Earlier Clinical InsightsIRVINE, Calif., Oct. 17, 2026 /PRNewswire/ -- Masimo, a Danaher company and a…

Continue ReadingMasimo’s smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

Vivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T Therapy GT801 in Autoimmune Hemolytic Anemia

  • Post author:
  • Post category:Sales & Growth

SHANGHAI, Oct. 17, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta Bio"), a company spun out of the in vivo CAR-T platform of Beijing Grit Biotherapeutics Co., Ltd. ("Grit Bio"), today announced that the U.S. Food and…

Continue ReadingVivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T Therapy GT801 in Autoimmune Hemolytic Anemia

SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  • Post author:
  • Post category:Sales & Growth

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programsLatest long-term and real-world data with SKYRIZI®(risankizumab) and RINVOQ® (upadacitinib) provide additional insight into clinical and endoscopic outcomes over approximately three years in…

Continue ReadingSKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

Lanoi Dermatology welcomes board-certified dermatologist and Mohs surgeon Hannah Berman, MD

  • Post author:
  • Post category:Sales & Growth

Dr. Berman expands access to skin cancer surgery, reconstruction and physician-led cosmetic dermatology in San DiegoSAN DIEGO, Oct. 15, 2026 /PRNewswire/ -- Lanoi Dermatology has welcomed Hannah Sophie Berman, MD, a board-certified dermatologist and fellowship-trained Mohs surgeon, to…

Continue ReadingLanoi Dermatology welcomes board-certified dermatologist and Mohs surgeon Hannah Berman, MD

GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration

  • Post author:
  • Post category:Sales & Growth

Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project ExecutionSEOUL, South Korea and RALEIGH, N.C., Oct. 12, 2026 /PRNewswire/ -- GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho,…

Continue ReadingGCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration

On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association ‘Ehtiwaa’ Collaborate to Support People Living with Schizophrenia Through the ‘Small Wins’ Initiative

  • Post author:
  • Post category:Sales & Growth

 More than 70 personalized 'Small Wins' toolkits, assembled by Bristol Myers Squibb employees, were designed to encourage everyday engagement, self-recognition and emotional well-being among people living with schizophrenia in Saudi Arabia.RIYADH, Saudi Arabia, Oct. 12, 2026 /PRNewswire/ --…

Continue ReadingOn the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association ‘Ehtiwaa’ Collaborate to Support People Living with Schizophrenia Through the ‘Small Wins’ Initiative